Back to Selection     Print       Date : 30 Apr 2026
Fund Summary
UTI Healthcare Fund (G)
[Equity: Sectoral]  
 
Fund Details
Fund Type Growth Launch Date 28-Jun-99
Corpus(Cr.) 1144.0 Latest NAV 312.9534 As on 12-06-2026
Equity(%) 95.27 52 Week High 312.953
Debt(%) 4.73 52 Week Low 268.586
Others(%) 0.0 Exit Load 1% for redemption within 30 days
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 2.30
Scheme Benchmark BSE Healthcare TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Kamal Gada
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 27.82%
Top 10 Holdings 44.50%
Top 25 Holdings 79.16%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Pharma & Biotech 68.83
Healthcare 24.45
Cash 4.72
Chemicals 1.99
Others 0.01
 
 
 
 
 
Portfolio Metrics
PB Ratio 5.30
PE Ratio 39.25
 
Top 25 Holdings
Holdings Net Asset(%)
Sun Pharmaceutical Industries Limited 9.49
Ajanta Pharma Limited 5.84
NET CURRENT ASSETS 4.72
Lupin Limited 4.23
Apollo Hospitals Enterprise Limited 3.54
DIVI LABORATORIES LTD 3.45
Dr Reddys Laboratories Limited 3.35
Glenmark Pharmaceuticals Limited 3.35
Gland Pharma Limited 3.30
Fortis Health Care Ltd 3.23
Alkem Laboratories Limited 3.21
Max Healthcare Institute Limited 3.00
Cohance Lifesciences Limited 2.96
Anthem Biosciences Limited 2.48
Aurobindo Pharma Limited 2.46
Procter & Gamble Health Limited 2.28
IPCA Laboratories Limited 2.19
Caplin Point Laboratories Limited 2.17
Sai Life Sciences Limited 2.15
EQ- GLOBAL HEALTH LTD. 2.06
Sudeep Pharma Limited 1.99
(5) Total outstanding exposure in derivative instruments as on April 30, 2026 is Rs. Nil. 1.99
Sequent Scientific Limited 1.95
EQ- JUPITER LIFE LINE HOSPITALS LTD 1.94
Marksans Pharma Limited 1.83

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
2.28% 13.12% 8.95% 10.03%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
0.09% 2.31% -8.96% -3.41%
 
Scheme Benchmark [NSE - Nifty Healthcare TRI]
-1.19% 6.59% 5.70% 9.27%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
15.03% 26.04% 13.84% 13.71%
 
 
1.41% 9.21% 9.61% 12.64%
 
 
11.76% 23.30% 12.96% 10.95%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
UTI Healthcare Fund (G) 16.56% 1.2288 11.1648% 42.6052 0.1615
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
UTI Healthcare Fund (G) 17.7049% 0.0003 0.3183 14.1167 1.4982
 
Back to Selection